➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Merck
Dow
McKesson
McKinsey

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

TERAZOSIN HYDROCHLORIDE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Terazosin Hydrochloride patents expire, and when can generic versions of Terazosin Hydrochloride launch?

Terazosin Hydrochloride is a drug marketed by Apnar Pharma Lp, Beximco Pharms Usa, Heritage Pharma, Hikma, Jubilant Cadista, Mylan, Mylan Technologies, Ranbaxy Labs Ltd, Ivax Sub Teva Pharms, Sandoz, and Teva. and is included in twelve NDAs.

The generic ingredient in TERAZOSIN HYDROCHLORIDE is terazosin hydrochloride. There are twenty-four drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the terazosin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Terazosin Hydrochloride

A generic version of TERAZOSIN HYDROCHLORIDE was approved as terazosin hydrochloride by APNAR PHARMA LP on March 30th, 1998.

  Try it Free

Drug patent expirations by year for TERAZOSIN HYDROCHLORIDE
Recent Clinical Trials for TERAZOSIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Qiang ZhangPhase 1
University of IowaPhase 1
Michael J. Fox Foundation for Parkinson's ResearchPhase 1

See all TERAZOSIN HYDROCHLORIDE clinical trials

Pharmacology for TERAZOSIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TERAZOSIN HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
HYTRIN TABLET;ORAL terazosin hydrochloride 019057
HYTRIN CAPSULE;ORAL terazosin hydrochloride 020347

US Patents and Regulatory Information for TERAZOSIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074315-003 Dec 31, 1998 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ranbaxy Labs Ltd TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 076021-004 Aug 22, 2002 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Teva TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074446-001 May 18, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Mylan Technologies TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075384-004 Dec 1, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ivax Sub Teva Pharms TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074530-001 Apr 21, 2000 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Ranbaxy Labs Ltd TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 076021-001 Aug 22, 2002 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-001 Mar 30, 1998 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Merck
Dow
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.